Skip to main content
HR 4733 115th Congress House Health Charitable contributions Congressional oversight Department of Health and Human Services Drug therapy Drug trafficking and controlled substances Health information and medical records Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Income tax credits Medical research National Institutes of Health (NIH) Prescription drugs Research administration and funding Research and development Social work, volunteer service, charitable organizations User charges and fees

Opioids and STOP Pain Initiative Act

Introduced: April 17, 2018 Introduced by: Welch, Peter Democratic · Vermont See on congress.gov
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 3, 2018
Referred to the Subcommittee on Health.
Dec 22, 2017
Referred to the Subcommittee on Health.
Dec 21, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 21, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Opioids and STOP Pain Initiative Act

This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:

  • understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
  • improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
  • supporting the Federal Pain Research Strategy.

NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.

What's happening now January 3, 2018

Referred to the Subcommittee on Health.

 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4733: Opioids and STOP Pain Initiative Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-4733/
MLA
"H.R. 4733: Opioids and STOP Pain Initiative Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-4733/.
Bluebook (legal)
H.R. 4733, 115th Cong. (2026), https://openamerica.io/bill/115-HR-4733/.
Markdown link
[H.R. 4733: Opioids and STOP Pain Initiative Act](https://openamerica.io/bill/115-HR-4733/)
Report a problem